Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Repligen Corp (NQ: RGEN ) 136.71 -2.33 (-1.68%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Repligen Corp < Previous 1 2 3 4 5 6 Next > Repligen Earnings Conference Call Is Coming Up, Here's What You Need To Know April 20, 2022 Repligen (NASDAQ:RGEN) will host a conference call at 08:30 AM ET on April 27, 2022, to discuss Q1 2022 earnings results. How to Attend Repligen (RGEN) Conference Call Follow this link to access the... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday April 19, 2022 On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was... Via Benzinga Repligen's Q4 Earnings Beat Expectations, Issues Solid FY22 Guidance February 17, 2022 Repligen Corp (NASDAQ: RGEN) Via Benzinga Earnings Scheduled For February 17, 2022 February 17, 2022 Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. Via Benzinga Earnings Scheduled For October 28, 2021 October 28, 2021 Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •... Via Benzinga Elephant Tracking: How to Spot the Market’s Next Mega Winners BEFORE They Take Off April 11, 2022 If you follow an elephant's tracks, you find an elephant. If you follow a large money manager, you'll find the winners they've identified. Via InvestorPlace Repligen Earnings Perspective: Return On Capital Employed February 18, 2022 Pulled from Benzinga Pro data, Repligen (NASDAQ:RGEN) showed a loss in earnings since Q3, totaling $29.11 million. Sales, on the other hand, increased by 4.66% to $186.52 million during Q4. Via Benzinga 10 Biggest Price Target Changes For Friday February 18, 2022 Needham lowered Fiverr International Ltd. (NYSE: FVRR) price target from $205 to $100. Fiverr International shares gained 2% to $80.00 in pre-market trading. Wedbush cut the... Via Benzinga The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios February 17, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel... Via Benzinga The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More February 13, 2022 Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... Via Benzinga This Foreboding Sign Looms Over Repligen's Chart February 02, 2022 If history is any guide, there may be trouble ahead for shares of Repligen (NASDAQ:RGEN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be... Via Benzinga Repligen Stock Shows Leadership With 86 RS Rating December 14, 2021 A RS Rating upgrade for Repligen stock shows improving technical performance for the top-ranked firm in the Medical Products group. Via Investor's Business Daily Repligen Corp (RGEN) Q3 2021 Earnings Call Transcript October 28, 2021 RGEN earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug October 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In... Via Benzinga 3 Unstoppable Healthcare Stocks to Buy With Just $1,000 September 22, 2021 It doesn't take much when you buy great companies and let them grow. Via The Motley Fool 10 Biggest Price Target Changes For Friday September 17, 2021 UBS cut FedEx Corporation (NYSE:FDX) price target fr... Via Benzinga The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More October 24, 2021 Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... Via Benzinga Exposures Product Safety Repligen Reinforces Proteins Business With $150M Avitide Acquisition Deal September 16, 2021 Repligen Corporation (NASDAQ: RGEN) has agreed to acquire privately-held Avitide Inc for approximately $150 million in cash and stock. The deal consideration includes $75 million... Via Benzinga Chief Executive Officer Of Repligen Trades $8.18 Million In Company Stock September 14, 2021 Anthony Hunt, Chief Executive Officer at Repligen (NASDAQ:RGEN), made a large buy and sell of company shares on September 9, according to a new SEC filing. What Happened: A Form 4... Via Benzinga Topics Regulatory Compliance Exposures Legal Regulatory Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021 October 14, 2021 Upgrades According to Roth Capital, the prior rating for Ring Energy Inc (AMEX: Via Benzinga Repligen Senior VP Makes $1.13 Million Sell September 02, 2021 Ralf Kuriyel, Senior VP and RD at Repligen (NASDAQ:RGEN), made a large insider sell on August 30, according to a new SEC filing. What Happened: A Form 4 filing from the U.S.... Via Benzinga Topics Regulatory Compliance Exposures Legal Regulatory The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug September 30, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data September 23, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs September 22, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (... Via Benzinga The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data September 21, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold September 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (... Via Benzinga The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study September 16, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... Via Benzinga The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod September 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself September 03, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... Via Benzinga The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab September 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... Via Benzinga Exposures COVID-19 Product Safety < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.